反流监测的现代方法:何时、选用何种及如何操作
本文综述现代反流监测技术,包括无线pH监测和24小时导管pH-阻抗监测,并基于里昂共识2.0框架讨论检测时机、方式选择及临床应用场景。文章强调根据症状表型、临床指征和患者耐受性选择个体化监测策略,并区分未证实GERD与已证实GERD的检测条件。
要点
- 无线pH监测可延长至96小时以捕捉GERD日间变异,但仅测远端酸反流。
- pH-阻抗监测可检测所有反流事件并评估黏膜完整性,但导管不适限制监测至24小时。
- 未证实GERD者应停酸抑制治疗检测,已证实GERD且症状持续者应在酸抑制下检测。
核心结论
- 反流监测是评估和管理食管症状的有价值工具,检测策略应基于症状表型、临床指征和患者耐受性个体化选择。
研究设计与样本
- 本文为综述,比较无线pH监测与24小时导管pH-阻抗监测的技术特点及临床应用场景,并引用里昂共识2.0框架。
主要发现
- 无线pH监测优势为患者舒适且可延长至96小时以考虑GERD日间变异,但仅测量远端酸反流。
- pH-阻抗监测可检测所有反流事件、表征反流物内容、识别近端反流范围并测量基线黏膜阻抗,但导管引起不适且监测限于24小时。
- 反流监测指标结合内镜及高分辨率测压等辅助检查,可依据里昂共识2.0框架为病理性反流提供确证或支持证据。
关键数值与推荐
- 未证实GERD的患者应在停酸抑制治疗下进行检测。
- 已证实GERD且优化抗反流治疗后症状持续者,应在酸抑制下进行pH-阻抗监测。
- 典型可感知症状(烧心、胸痛)且需内镜时,可同期进行无线监测。
- 以反流和嗳气为主要症状者优选pH-阻抗监测,不典型症状两者均可选。
- 前肠术后症状评估可考虑反流监测,但术后阈值和最佳检测方法尚无共识。
临床怎么用
- 根据患者症状表型(典型 vs 不典型、反流/嗳气 vs 烧心/胸痛)选择无线pH或pH-阻抗监测。
- 检测前确认患者是否已证实GERD,以决定停用或继续酸抑制治疗。
- 需内镜的典型症状患者可同期行无线pH监测以提高效率。
局限性
- 前肠术后反流监测的阈值和最佳检测方法尚无共识。
- 无线pH监测仅测量远端酸反流,不检测非酸反流。
- pH-阻抗监测因导管不适限制监测时间为24小时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Modern reflux monitoring technology provides for both prolonged wireless and 24-hour catheter-based testing options. Wireless pH monitoring offers the advantages of patient comfort and prolonged assessment for up to 96 hours to account for day-to-day variation of GERD, but only distal acid reflux is measured. pH-impedance monitoring detects all reflux episodes regardless of acidity, characterizes refluxate content, identifies proximal extent, and measures baseline mucosal impedance which reflects mucosal integrity as well as longitudinal reflux-related injury, but the indwelling catheter causes patient discomfort and limits monitoring to 24 hours. Metrics from reflux monitoring and findings from endoscopy, together with adjunctive tests such as high-resolution manometry, can provide conclusive and/or supportive evidence for or against pathologic reflux, utilizing the Lyon Consensus 2.0 framework. Selection of optimal testing strategy should depend on presenting symptom phenotypes, clinical indications and scenarios, local testing options, and patient tolerance. Testing should be performed off acid suppressive therapy for patients with unproven GERD, while those with proven GERD and persistent symptoms despite optimized anti-reflux therapy should undergo pH-impedance monitoring on acid suppression. If endoscopy is indicated, wireless monitoring can be performed at the same setting, especially for typical perceptive (heartburn, chest pain) symptoms. pH-impedance monitoring is preferred for primary regurgitation and belching, while both modalities are options for atypical symptoms. Reflux monitoring may be indicated for assessing symptoms after foregut interventions, although no consensus on post-operative thresholds or optimal testing methodology has been established. Reflux monitoring is a valuable tool for evaluating and directing management of esophageal symptoms.
引用
- Chan WW, Schroeder MK, Hayat MH, et al. Modern Approach to Reflux Testing: When, Which, and How? Am J Gastroenterol. 2026. PMID: 42866979. doi:10.14309/ajg.0000000000004232
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。